WELENT Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹774 Cr
verified against source
Revenue YoY
—
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Welspun Enterprises reported a soft Q1 FY27 with consolidated revenue of ₹774 crore impacted by geopolitical supply chain disruptions, Mumbai construction stoppages, and labor migration during elections. EBITDA margin remained resilient at 22.9%, well above the 18% guidance, reflecting disciplined cost management. PAT from continuing operations stood at ₹90 crore, with reported PAT at ₹56 crore including ₹34 crore loss from discontinued MCP operations. Key milestones include the ₹1,000 crore AntasMaria HAM divestment (expected Q2 closure), Dharavi Gettar tunnel approvals received, and Pune Shirur sub-concession executed. The order book stands at ₹18,700 crore providing 3.5 years of revenue visibility. Management targets 15-20% annualized growth for FY27 but expects execution acceleration in H2. WMEL posted ₹179 crore revenue with 21.3% margins. Geopolitical uncertainty and delayed order inflows remain key risks to growth guidance.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects to be in growth phase closer to 15% than 20%, dependent on geopolitical conditions and commodity availability. Order book visibility provides confidence.
- Appointed date expected in Q3 FY27 following sub-concession agreement execution. Financial closure and con-date declaration will trigger construction ramp-up.
- Company maintains 18%+ EBITDA margin guidance, having delivered 22.9% in Q1 FY27 and 22.8% in FY26, demonstrating execution model strength.
- Pipeline opportunities of ~₹30,000 crore tracked in water treatment space (40% Maharashtra, 60% outside). H1 inflows may shift to H2.
Risks flagged
- Analyst raised concern about persistent revenue degrowth. Management attributed Q1 softness to external factors but acknowledged execution momentum needs to accelerate in H2 to achieve 15% growth target.
- Ongoing geopolitical disruptions causing material availability issues and cost volatility. Management admits these are beyond company control and difficult to forecast.
- FDP approval pending from DGH/MOPNG (expected in 4-6 weeks). Production timeline post-approval is ~2 years. Strategic direction (hold vs exit) remains undecided pending FDP clearance.
- Multiple project approvals and milestones (Dharavi tunnel, Pune Shirur appointed date) were delayed to Q1. Execution must accelerate materially in H2 to meet growth guidance.
Key quotes
- The confidence comes out of the order book versus our target to grow—we have an order book of almost three and a half years, so we have very strong audit book... all statutory approvals are behind us and we are in clear for revenue recognition.
- The confidence is there to deliver growth. It will be more closer to 15% than 20% at this point in time. All will depend upon how things pan out and how the commodities availability and the associated challenges play out.
- These margins are because of technology play. We are not playing as run-of-the-mill water projects. We target projects which offer technology play which allows us to be differentiated. We have associations and connects which allow us to differentiate.
Research modules